Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent vs. Abciximab and Bare-Metal Stent in Myocardial Infarction - STRATEGY


The goal of the trial was to evaluate the clinical and angiographic differences comparing treatment with a single, high-dose bolus of tirofiban plus sirolimus-eluting stenting (SES) versus abciximab plus bare-metal stenting (BMS) among patients with ST elevation myocardial infarction (STEMI).